• Asuragen Launches QuantideX® NGS RNA Lung Cancer Kit
    30th April 2017News

    Asuragen Launches QuantideX® NGS RNA Lung Cancer Kit

    Introducing A Highly Sensitive Targeted RNA Sequencing Panel for the Analysis of Gene Fusions and Expression Markers in Non-Small Cell Lung Cancer. The QuantideX® NGS RNA Lung Cancer Kit is a next [...]